About Us

The company was founded in 2016 by Dr Mridul Majumder with a simple motto “Quality Science Delivered on Time”.

Having a rich knowledge and decades of experience, especially in the solid-state analysis, the intention was to set M2M pharma as a company of choice for Material Characterisation with a special emphasis on developing methods for quantifying the small level of amorphous content in micronized samples. 


Today, we have all in-house technology that is running, with a principle to cGMP quality system, and supporting our clients regularly.

Get in touch
image1

Dr Mridul Majumder, Founder & Director

A pharmaceutical scientist with a PhD in Pharmaceutics. Prior to setting up M2M Pharmaceuticals Ltd., Mridul had worked for a CRO for 12 years in early-stage product development especially related to material science for respiratory drug delivery. 


In his professional career,  he had worked in principles to GMP as per the ICH Q8 and Q10, and well trained with Q7, Q9, and Q11. Mridul is a Fellow of Royal Society of Chemistry (FRSC), Member of Academy of Pharmaceutical Sciences (MAPS), Focus Group Member for Material Science at APS, Member of Aerosol Society, UK.


Mridul is an Honorary Lecturer at UCL School of Pharmacy, London.

Our Special Interests:

✓ Solid form selection

✓ Amorphous materials (intentional/unintentional)

✓ Batch-to-batch variability

✓ Batch-to-batch variability

✓ Amorphous materials (intentional/unintentional)

✓ Batch-to-batch variability

✓ Amorphous materials (intentional/unintentional)

✓ Amorphous materials (intentional/unintentional)

✓ Amorphous content determination with method development and validation

✓ Amorphous content determination with method development and validation

✓ Amorphous content determination with method development and validation

✓ Amorphous content determination with method development and validation

✓ Respiratory drug delivery

✓ Amorphous content determination with method development and validation

✓ Respiratory drug delivery

✓ Solid dispersion

✓ Amorphous content determination with method development and validation

✓ Respiratory drug delivery

✓ Co-crystallisation in solid-state

✓ Screening: Polymorphism, Co-crystals, Salts

✓ Screening: Polymorphism, Co-crystals, Salts

✓ Screening: Polymorphism, Co-crystals, Salts

✓ Screening: Polymorphism, Co-crystals, Salts

✓ Screening: Polymorphism, Co-crystals, Salts

We are immensely proud to have invaluable contacts within academia, industries and together we are providing a personalised and comprehensive solutions to the challenges our customers are facing every day. 


Our clients include start-up, virtual, spin out to major multinational companies from all over the world. We provide services to Pharmaceutical, Biotechnological, Biological, Food, Consumer Products, Cosmetics, Agricultural, Construction industries etc. 

Site Location

We have a State-of-the-art laboratory facility at the brand-new Thames Valley Science Park (TVSP) in Reading, UK. TVSP is an easy access site; located on M4 corridor between J10 and J11, which is just 25 miles from Heathrow Airport and 40 miles from central London.

laboratory
laboratory

How to reach us

M2M Pharmaceuticals Ltd

The Gateway Building, 1 Collegiate Square, Thames Valley Science Park (TVSP), Reading RG2 9LH, UK

T: + 44 (0) 118 304 1035 (direct) T: + 44 (0) 118 304 1002 (switch) M: + 44 (0) 7946 560263 E: mridul.majumder@m2mpharma.com W: www.m2mpharma.com